[go: up one dir, main page]

IS7373A - Aðferð til framleiðslu á flútikasón própíónati, einkum á fjölbreytilegu formi 1 - Google Patents

Aðferð til framleiðslu á flútikasón própíónati, einkum á fjölbreytilegu formi 1

Info

Publication number
IS7373A
IS7373A IS7373A IS7373A IS7373A IS 7373 A IS7373 A IS 7373A IS 7373 A IS7373 A IS 7373A IS 7373 A IS7373 A IS 7373A IS 7373 A IS7373 A IS 7373A
Authority
IS
Iceland
Prior art keywords
variety
production
forms
fluticasone propionate
fluticasone
Prior art date
Application number
IS7373A
Other languages
English (en)
Inventor
John Coote Steven
Kay Nice Rosalyn
David Wipperman Mark
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of IS7373A publication Critical patent/IS7373A/is

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IS7373A 2002-02-04 2004-07-26 Aðferð til framleiðslu á flútikasón própíónati, einkum á fjölbreytilegu formi 1 IS7373A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0202564.1A GB0202564D0 (en) 2002-02-04 2002-02-04 Process
PCT/EP2003/001115 WO2003066653A2 (en) 2002-02-04 2003-02-03 Process for the production of fluticasone propionate, in particular of polymorphic form 1

Publications (1)

Publication Number Publication Date
IS7373A true IS7373A (is) 2004-07-26

Family

ID=9930366

Family Applications (1)

Application Number Title Priority Date Filing Date
IS7373A IS7373A (is) 2002-02-04 2004-07-26 Aðferð til framleiðslu á flútikasón própíónati, einkum á fjölbreytilegu formi 1

Country Status (22)

Country Link
US (1) US20050222107A1 (is)
EP (1) EP1474436B1 (is)
JP (1) JP2005517019A (is)
KR (1) KR20040086331A (is)
CN (1) CN100338087C (is)
AR (1) AR038390A1 (is)
AT (1) ATE446965T1 (is)
AU (1) AU2003206836B2 (is)
BR (1) BR0307243A (is)
CA (1) CA2473896A1 (is)
CO (1) CO5611115A2 (is)
DE (1) DE60329824D1 (is)
GB (1) GB0202564D0 (is)
IS (1) IS7373A (is)
MX (1) MXPA04007530A (is)
NO (1) NO327138B1 (is)
NZ (1) NZ534320A (is)
PL (1) PL372214A1 (is)
RU (1) RU2333218C2 (is)
TW (1) TW200410982A (is)
WO (1) WO2003066653A2 (is)
ZA (1) ZA200405826B (is)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL153462A0 (en) * 2002-12-16 2003-07-06 Chemagis Ltd Thiocarboxylic acid organic salts and processes utilizing the same
DK2044099T3 (da) * 2006-06-14 2012-07-02 Generics Uk Ltd Fremgangsmåde til fremstillingen af s-fluormethyl-6,9-difluor-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1,4-dien-17-carbothiat og mellemprodukter
AU2013202835B2 (en) * 2006-06-14 2015-11-12 Generics [Uk] Limited Process for the preparation of S-fluoromethyl-6,9-difluoro-11-hydroxy-16-methyl-17-propionyloxy-3-oxo-androsta-1, 4-diene-17-carbothioate and intermediates
WO2012029077A2 (en) * 2010-09-01 2012-03-08 Cadila Healthcare Limited Process for preparing fluticasone propionate/furoate
KR20140048237A (ko) 2011-07-08 2014-04-23 화이자 리미티드 플루티카손 프로피오네이트 형태 1의 제조 방법
WO2013169647A1 (en) 2012-05-08 2013-11-14 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
DE102012221219B4 (de) * 2012-11-20 2014-05-28 Jesalis Pharma Gmbh Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2455976A1 (de) * 1974-11-27 1976-08-12 Merck Patent Gmbh Prostensaeurederivate
JPS56138200A (en) * 1980-02-15 1981-10-28 Glaxo Group Ltd Androstane carbothioate compound
US5783677A (en) * 1993-09-24 1998-07-21 Procter & Gamble Pharmaceuticals, Inc. Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds
US5488188A (en) * 1994-09-29 1996-01-30 Merrell Dow Pharmaceuticals Inc. Process for the preparation of (E)-1-amino-2-(fluoromethylene)-4-(p-fluorophenyl)butane, novel processes for preparing an intermediate thereof, and novel intermediates thereof
GB9622173D0 (en) * 1996-10-24 1996-12-18 Glaxo Group Ltd Particulate Products
GB9925934D0 (en) * 1999-11-03 1999-12-29 Glaxo Group Ltd Novel apparatus and process
ATE416184T1 (de) * 2000-08-05 2008-12-15 Glaxo Group Ltd 17.beta.-carbothioat 17.alpha.- arylkarbonyloxyloxy androstanderivate als anti- phlogistische medikamente

Also Published As

Publication number Publication date
BR0307243A (pt) 2004-12-14
AU2003206836B2 (en) 2009-01-08
KR20040086331A (ko) 2004-10-08
EP1474436B1 (en) 2009-10-28
EP1474436A2 (en) 2004-11-10
WO2003066653A2 (en) 2003-08-14
RU2333218C2 (ru) 2008-09-10
MXPA04007530A (es) 2004-11-10
CO5611115A2 (es) 2006-02-28
CN100338087C (zh) 2007-09-19
NO20043664L (no) 2004-09-01
WO2003066653A3 (en) 2003-12-24
RU2004122928A (ru) 2005-05-27
AU2003206836A1 (en) 2003-09-02
AR038390A1 (es) 2005-01-12
DE60329824D1 (de) 2009-12-10
JP2005517019A (ja) 2005-06-09
NO327138B1 (no) 2009-05-04
ZA200405826B (en) 2005-08-11
PL372214A1 (en) 2005-07-11
CA2473896A1 (en) 2003-08-14
US20050222107A1 (en) 2005-10-06
TW200410982A (en) 2004-07-01
NZ534320A (en) 2007-07-27
GB0202564D0 (en) 2002-03-20
ATE446965T1 (de) 2009-11-15
CN1642969A (zh) 2005-07-20

Similar Documents

Publication Publication Date Title
MX255058B (es) Derivados de pirazol y proceso para la produccion de los mismos.
NO20043345L (no) Fremgangsmate for fremstilling av hydrokarboner
IS2460B (is) Aðferð til framleiðslu á fituefnablöndu
IS6834A (is) Aðferð til framleiðslu á amlódipín maleati
IS6487A (is) Aðferð til framleiðslu á Sítalóprami
ATE434598T1 (de) Zwischenprodukte für die herstellung von dioxan-2-alkylcarbamaten
MXPA03007087A (es) Procedimiento para fabricacion de derivados de acido fenilacetico.
IS7239A (is) Aðferð til framleiðslu á essítalóprami
FR2846964B1 (fr) Procede de fabrication de 1,2-epoxy-3-chloropropane
FI20021899A0 (fi) Menetelmä kuitutuotteen valmistamiseksi
PL376399A1 (en) Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
EP1514870A4 (en) PRODRUG AND METHOD FOR THE PRODUCTION THEREOF
IS7373A (is) Aðferð til framleiðslu á flútikasón própíónati, einkum á fjölbreytilegu formi 1
EP1558772A4 (en) Production of titania
AU2003279281A1 (en) Automated processes for the production of garments
IS7834A (is) Aðferð til nýmyndunar á bensímídasólefnasambandi
NO20052997D0 (no) Celluloseprodukt og fremgangsmate for dets produksjon.
NO20031413L (no) Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
PL1482101T3 (pl) Element konstrukcyjny ściany, sposób wytwarzania elementu konstrukcyjnego ściany i środek łączący dla elementu konstrukcyjnego ściany
NO20053151D0 (no) Fremgangsmate for a produsere mikrosystemer.
NO20041224L (no) Fremgangsmate for fremstilling av hydrokarboner
TWI319391B (en) Process for the production of 3-methylthiopropanal
FR2833272B1 (fr) Nouvelles phytases et procede de production de ces phytases
NO20011467D0 (no) Stripefri dyptrekkbare og høytransparente polyamidfolier, en fremgangsmÕte for fremstilling av disse og deres anvendelse som innpakningsmateriale
AU2003288532A8 (en) Process for manufacturing fibrin membranes